Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1967 4
1969 2
1970 4
1971 2
1972 8
1973 8
1974 5
1975 9
1976 19
1977 5
1978 13
1979 10
1980 9
1981 16
1982 22
1983 21
1984 19
1985 24
1986 18
1987 23
1988 28
1989 35
1990 28
1991 29
1992 34
1993 25
1994 38
1995 27
1996 38
1997 33
1998 45
1999 32
2000 48
2001 63
2002 59
2003 86
2004 82
2005 84
2006 124
2007 118
2008 106
2009 122
2010 140
2011 153
2012 197
2013 185
2014 206
2015 215
2016 250
2017 290
2018 306
2019 302
2020 207
Text availability
Article attribute
Article type
Publication date

Search Results

3,545 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and management of psoriasis.
Kim WB, Jerome D, Yeung J. Kim WB, et al. Can Fam Physician. 2017 Apr;63(4):278-285. Can Fam Physician. 2017. PMID: 28404701 Free PMC article. Review.
OBJECTIVE: To provide primary care clinicians with an up-to-date and practical overview of the diagnosis and management of psoriasis. QUALITY OF EVIDENCE: PubMed, MEDLINE, EMBASE, and Cochrane databases were searched for relevant meta-analyses, randomized controlled …
OBJECTIVE: To provide primary care clinicians with an up-to-date and practical overview of the diagnosis and management of psoriasis. …
Diet and psoriasis.
Pona A, Haidari W, Kolli SS, Feldman SR. Pona A, et al. Dermatol Online J. 2019 Feb 15;25(2):13030/qt1p37435s. Dermatol Online J. 2019. PMID: 30865402 Free article. Review.
METHODS: Terms "psoriasis AND diet" were used to search PubMed database and 63 articles describing dietary changes influencing psoriasis were selected. ...A randomized, double-blind, placebo-controlled study investigating selenium supplementation in psoria
METHODS: Terms "psoriasis AND diet" were used to search PubMed database and 63 articles describing dietary changes influencing pso
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E, Chaimani A, Garcia-Doval I, Do G, Hua C, Mazaud C, Droitcourt C, Hughes C, Ingram JR, Naldi L, Chosidow O, Le Cleach L. Sbidian E, et al. Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. PMID: 29271481 Free PMC article. Updated. Review.
Several randomised controlled trials (RCTs) have compared the efficacy of the different systemic treatments in psoriasis against placebo. ...SELECTION CRITERIA: Randomised controlled trials (RCTs) of systemic and biological treatments in adults (over 18 years …
Several randomised controlled trials (RCTs) have compared the efficacy of the different systemic treatments in psoriasis again …
Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study.
Iversen L, Eidsmo L, Austad J, de Rie M, Osmancevic A, Skov L, Talme T, Bachmann I, van de Kerkhof P, Stahle M, Banerjee R, Oliver J, Fasth AER, Frueh J. Iversen L, et al. J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1930-1939. doi: 10.1111/jdv.14979. Epub 2018 Jul 15. J Eur Acad Dermatol Venereol. 2018. PMID: 29633373 Clinical Trial.
METHODS: One hundred and sixty subjects aged 18-50 years with new-onset (≤12 months) moderate-to-severe plaque psoriasis and naïve to systemic treatment and phototherapy will be randomized to secukinumab 300 mg or nb-UVB. ...CONCLUSIONS: STEPIn is the first study to …
METHODS: One hundred and sixty subjects aged 18-50 years with new-onset (≤12 months) moderate-to-severe plaque psoriasis and naïve to …
Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: A Randomized Controlled Clinical Trial.
Navarro-López V, Martínez-Andrés A, Ramírez-Boscá A, Ruzafa-Costas B, Núñez-Delegido E, Carrión-Gutiérrez MA, Prieto-Merino D, Codoñer-Cortés F, Ramón-Vidal D, Genovés-Martínez S, Chenoll-Cuadros E, Pérez-Orquín JM, Picó-Monllor JA, Chumillas-Lidón S. Navarro-López V, et al. Acta Derm Venereol. 2019 Nov 1;99(12):1078-1084. doi: 10.2340/00015555-3305. Acta Derm Venereol. 2019. PMID: 31453631 Free article. Clinical Trial.
The aim of this 12-week randomized, double-blind, placebo-controlled trial was to determine the efficacy and safety of a probiotic mixture in the reduction of psoriasis severity. Ninety 18-70-year-old adults with plaque psoriasis were randomized into p …
The aim of this 12-week randomized, double-blind, placebo-controlled trial was to determine the efficacy and safety of a probiotic mi …
Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial.
Armstrong AW, Chambers CJ, Maverakis E, Cheng MY, Dunnick CA, Chren MM, Gelfand JM, Wong DJ, Gibbons BM, Gibbons CM, Torres J, Steel AC, Wang EA, Clark CM, Singh S, Kornmehl HA, Wilken R, Florek AG, Ford AR, Ma C, Ehsani-Chimeh N, Boddu S, Fujita M, Young PM, Rivas-Sanchez C, Cornejo BI, Serna LC, Carlson ER, Lane CJ. Armstrong AW, et al. JAMA Netw Open. 2018 Oct 5;1(6):e183062. doi: 10.1001/jamanetworkopen.2018.3062. JAMA Netw Open. 2018. PMID: 30646223 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: The Patient-Centered Outcomes Research Institute Psoriasis Teledermatology Trial is a 12-month, pragmatic, randomized clinical equivalency trial to evaluate the effect of an online model for psoriasis compared with in-person …
DESIGN, SETTING, AND PARTICIPANTS: The Patient-Centered Outcomes Research Institute Psoriasis Teledermatology Trial is a 12-month, pr …
Effects of fish oil supplement on psoriasis: a meta-analysis of randomized controlled trials.
Yang SJ, Chi CC. Yang SJ, et al. BMC Complement Altern Med. 2019 Dec 5;19(1):354. doi: 10.1186/s12906-019-2777-0. BMC Complement Altern Med. 2019. PMID: 31805911 Free PMC article.
METHODS: We searched CENTRAL, Embase and MEDLINE on 24 January 2018 for randomized control trials (RCTs) on the effects of fish oil supplement in treating psoriasis. ...We performed a random-effects model meta-analysis to obtain the pooled treatment effect es …
METHODS: We searched CENTRAL, Embase and MEDLINE on 24 January 2018 for randomized control trials (RCTs) on the effects of fish oil s …
Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Fu Y, Lee CH, Chi CC. Fu Y, et al. JAMA Dermatol. 2018 Dec 1;154(12):1417-1423. doi: 10.1001/jamadermatol.2018.3631. JAMA Dermatol. 2018. PMID: 30422277 Free PMC article.
However, the association between psoriasis and inflammatory bowel disease (IBD) has been largely unclear. OBJECTIVE: To investigate the association of psoriasis with IBD. ...Crohn disease and ulcerative colitis were analyzed separately and random-effects mode …
However, the association between psoriasis and inflammatory bowel disease (IBD) has been largely unclear. OBJECTIVE: To investigate t …
Nutritional strategies for psoriasis: current scientific evidence in clinical trials.
Zuccotti E, Oliveri M, Girometta C, Ratto D, Di Iorio C, Occhinegro A, Rossi P. Zuccotti E, et al. Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8537-8551. doi: 10.26355/eurrev_201812_16554. Eur Rev Med Pharmacol Sci. 2018. PMID: 30556896 Free article.
Randomized controlled trials (RCTs) on beneficial botanical oral supplements were also included in the analysis. MATERIALS AND METHODS: For each topic, a search was conducted in MEDLINE electronic databases for articles published in English between January 1, 1990 and Sept
Randomized controlled trials (RCTs) on beneficial botanical oral supplements were also included in the analysis. MATERIALS AND METHOD
Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years.
Griffiths CEM, Papp KA, Kimball AB, Randazzo B, Song M, Li S, Shen YK, Blauvelt A. Griffiths CEM, et al. J Drugs Dermatol. 2018 Aug 1;17(8):826-832. J Drugs Dermatol. 2018. PMID: 30124721 Clinical Trial.
BACKGROUND: Due to the chronic nature of psoriasis, it is important to assess the sustained response of treatments over time. ...METHODS: Patients were randomized to placebo, guselkumab, or adalimumab at baseline. Placebo-randomized patients crossed over to g …
BACKGROUND: Due to the chronic nature of psoriasis, it is important to assess the sustained response of treatments over time. ...METH …
3,545 results
Jump to page
Feedback